AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
NEXGEL, Inc. has announced a $950,000 registered direct offering and concurrent private placement, issuing 413,044 shares of common stock at $2.30 per share. The company also agreed to issue unregistered warrants to purchase up to 206,522 shares of common stock at an exercise price of $4.25 per share. The registered direct offering and private placement are expected to close on August 4, 2025.
NEXGEL, Inc. (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels, has announced a $950,000 registered direct offering and a concurrent private placement. The company will issue 413,044 shares of common stock at $2.30 per share. Additionally, NEXGEL has agreed to issue unregistered warrants to purchase up to 206,522 shares of common stock at an exercise price of $4.25 per share. The unregistered warrants are exercisable immediately upon issuance with a five-year term. The registered direct offering and private placement are expected to close on August 4, 2025.Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet